WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention
WHO recommended that the dapivirine vaginal ring (DPV-VR) may be offered as an additional prevention choice for women at substantial risk[1] of HIV infection as part of combination prevention approaches.